Jun Fei Feng
Director of Finance/CFO at Beijing Shenogen Pharma Group Ltd.
Profile
Jun Fei Feng is currently the CFO, Board Secretary & Deputy GM at Beijing Shenogen Pharma Group Ltd.
He previously worked as a Secretary at Beijing Hanbang Technology Corp.
Mr. Feng graduated from Central University of Finance & Economics with a graduate degree in 2008 and from Northwest University of Politics & Law with an undergraduate degree in 2005.
Jun Fei Feng active positions
Companies | Position | Start |
---|---|---|
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Director of Finance/CFO | 2019-08-31 |
Former positions of Jun Fei Feng
Companies | Position | End |
---|---|---|
BEIJING HANBANG TECHNOLOGY CORP. | Corporate Secretary | - |
Training of Jun Fei Feng
Northwest University of Politics & Law | Undergraduate Degree |
Central University of Finance & Economics | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
BEIJING HANBANG TECHNOLOGY CORP. | Electronic Technology |
Private companies | 1 |
---|---|
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Health Technology |
- Stock Market
- Insiders
- Jun Fei Feng